Answers are grounded in this paper and cite their sources.
Develops a new antimicrobial sponge for chronic wound healing, indicating significant efficacy.
Chronic non-healing wounds remain a formidable clinical challenge on a global scale, inflicting heavy socioeconomic burdens and severely compromising life quality of patients. Negative pressure wound therapy (NPWT), the first-line mainstay for chronic wound management, boasts well-proven efficacy in exudate removal and granulation tissue promotion, generally with polyurethane (PU) sponges serving as an indispensable component of NPWT systems. However, commercial clinical NPWT PU sponges lack intrinsic antimicrobial activity, leaving wounds highly vulnerable to invasive bacterial infection. The clinically complementary polyvinylpyrrolidone-iodine (PVP-I) is readily rinsed away under continuous negative pressure, precluding long-acting antibacterial effects. To address this critical unmet clinical need, this research develops a robust antimicrobial coating based on the rapid redox crosslinking reaction between styrene-butadiene-styrene block copolymer (SBS) and iodine (I 2 ). This coating features ready preparation, convenient operation, and broad applicability across substrates. When applied to PU sponges, the coating forms an SBS-I-coated PU (SBS-I-PU) sponge that exhibits superior rinse resistance, sustained antimicrobial activity, and lower cytotoxicity compared to the PVP-I-coated PU (PVP-I-PU) sponge. This integrated therapeutic system significantly accelerates wound healing in rat and diabetic pig models, validating its strong potential as a promising new solution for the clinical management of chronic wounds.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: